Danaparoid and heparin-induced thrombocytopenia Patient Reports February 09, 2010

Danaparoid Side Effects Report #6085320-X
Danaparoid side effect was reported by a Physician from FRANCE on Feb 13, 2009. Male patient, 80 years of age, was diagnosed with thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, femoral artery occlusion, haematoma, heparin-induced thrombocytopenia, multi-organ failure, peripheral ischaemia, renal failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, AMIODARONE, FUROSEMIDE, AUGMENTIN, ACETYLSALICYLATE LYSINE. Patient died.

Danaparoid Side Effects Report #5093416-4
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Aug 22, 2006. Female patient, 78 years of age, was diagnosed with phlebitis deep, thrombophlebitis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with PHENOBARBITAL. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5275224-4
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Mar 08, 2007. Female patient, 78 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: deep vein thrombosis , disease recurrence, heparin-induced thrombocytopenia, pulmonary embolism . Danaparoid dosage: unknown. During the same period patient was treated with TRIMEBUTINE MALEATE, ACETAMINOPHEN, MORPHINE SULPHATE, MACROGOL, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5097841-7
Danaparoid side effect was reported by a Consumer or non-health professional from CANADA on Aug 29, 2006. Female patient, 78 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, pulmonary embolism , respiratory gas exchange disorder. Danaparoid dosage: unknown. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #5119938-5
Danaparoid side effect was reported by a Consumer or non-health professional from CANADA on Aug 29, 2006. Female patient, 78 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, heparin-induced thrombocytopenia, pulmonary embolism , respiratory gas exchange disorder. Danaparoid dosage: unknown. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5314613-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Apr 22, 2004. Male patient, 64 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: abdominal pain , adrenal insufficiency, circulatory collapse, confusional state, haemorrhage, heparin-induced thrombocytopenia, necrosis, pyrexia, urine sodium increased. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient recovered.

Danaparoid Side Effects Report #4863936-3
Danaparoid side effect was reported by a Health Professional from FRANCE on Dec 12, 2005. Female patient, 71 years of age, was diagnosed with cardiovascular disorder and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, jaundice , leg amputation, pain . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4886909-3
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 12, 2006. Female patient, 71 years of age, was diagnosed with cardiovascular disorder and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, embolism, heparin-induced thrombocytopenia, jaundice , leg amputation, pain . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.

Danaparoid Side Effects Report #5104110-5
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Aug 28, 2006. Male patient, 89 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, FUROSEMIDE, FERROUS FUMARATE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #6050177-X
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 15, 2009. Female patient, 80 years of age, was diagnosed with thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, femoral artery occlusion, haematoma, heparin-induced thrombocytopenia, peripheral ischaemia. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, AMIODARONE, FUROSEMIDE, AUGMENTIN, ACETYLSALICYLATE LYSINE. Patient died.

Danaparoid Side Effects Report #4937104-0
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Feb 24, 2006. Male patient, child 8 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: deep vein thrombosis , heparin-induced thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5093079-8
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Aug 21, 2006. Female patient, 77 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, immunology test abnormal. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN CALCIUM. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #4677920-6
Danaparoid side effect was reported by a Consumer or non-health professional from on May 20, 2005. Male patient, 75 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaphylactic shock, haematoma, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.

Danaparoid Side Effects Report #4883905-7
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 10, 2006. Male patient, 75 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaphylactic shock, haematoma, heparin-induced thrombocytopenia, procedural complication. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.


Danaparoid Side Effects Report #4891302-3
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 12, 2006. Male patient, 71 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: arterial thrombosis, heparin-induced thrombocytopenia, leg amputation, peripheral ischaemia. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, HEPARIN CALCIUM. Patient recovered.

Danaparoid Side Effects Report #4802369-2
Danaparoid side effect was reported by a Consumer or non-health professional from NETHERLANDS on Sept 29, 2005. Male patient, 69 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, peripheral ischaemia, pneumonia , pulse absent, thrombosis, white clot syndrome. Danaparoid dosage: unknown. During the same period patient was treated with METOPROLOL, RANITIDINE, DIAZEPAM, GLYCERYL TRINITRATE, HEPARIN, ILOPROST, ACENOCOUMAROL. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5132974-8
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Oct 10, 2006. Male patient, 67 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cyanosis, disseminated intravascular coagulation, heparin-induced thrombocytopenia, intestinal ischaemia, pain , septic shock, thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, ASPIRIN, FUROSEMIDE. Patient recovered.

Danaparoid Side Effects Report #5129258-0
Danaparoid side effect was reported by a Health Professional from FRANCE on Sept 29, 2006. Male patient, 65 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaphylactic shock, cross sensitivity reaction, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient recovered.

Danaparoid Side Effects Report #5053983-3
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on July 06, 2006. Male patient, 61 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemodialysis, haemodynamic instability, heparin-induced thrombocytopenia, renal failure acute, septic shock. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN CALCIUM, AVULAR, RAMIPRIL, FUROSEMIDE, POLYSTYRENE SULFONATE, INSULIN, ACENOCOUMAROL. Patient was hospitalized. Patient died.


Danaparoid Side Effects Report #5176358-5
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Dec 01, 2006. Male patient, 61 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anti-platelet antibody positive, haemodialysis, haemodynamic instability, heparin-induced thrombocytopenia, neuropathic arthropathy, osteitis, platelet aggregation abnormal, refusal of treatment by patient, renal failure acute. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN CALCIUM, RETOROLAC TROMETHAMINE, RAMIPRIL, FUROSEMIDE, POLYSTYRENE SULFONATE, INSULIN, ACENOCOUMAROL. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4907161-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 30, 2006. Female patient, 52 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, pancreatitis, pulmonary embolism . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, NADROPARIN CALCIUM. Patient recovered.

Danaparoid Side Effects Report #6130925-0
Danaparoid side effect was reported by a Consumer or non-health professional from AUSTRALIA on Mar 18, 2009. Male patient, 44 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. Patient died.

Danaparoid Side Effects Report #6111485-7
Danaparoid side effect was reported by a Health Professional from FRANCE on Feb 24, 2009. Male patient, 26 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: axillary vein thrombosis, heparin-induced thrombocytopenia, subclavian vein thrombosis, thrombophlebitis, vena cava thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with LEPIRUDIN, CISPLATIN, METHXLPREDNISOLONE SUCCINATE, CHLORPROMAZINE HYDROCHLORIDE, TRIMEBUTINE MALEATE, ONDANSETRON HYDROCHLORIDE, CLORAZEPATE DIPOTASSIUM, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.